arrow
K

Kenji Watanabe

University of Toyama
H指数:50
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness, safety, and clinical outcomes of treatment with the oral α4-integrin antagonist carotegrast methyl in patients with active ulcerative colitis: a multicenter observational study (CANAL study)

奥法木单抗(carotegrast methyl)口服α4整合素拮抗剂治疗活动性溃疡性结肠炎的有效性、安全性和临床结局:一项多中心观察性研究(CANAL研究)

2026-09-280
OAAI
ASO Visual Abstract: Survival Benefit of Adjuvant S-1 Chemotherapy in Patients Aged ≥ 80 Years with Gastric Cancer after Curative Resection—A Multicenter Cohort Study

ASO视觉摘要:≥80岁胃癌根治性切除术后辅助S-1化疗的生存获益——一项多中心队列研究

2025-10-170
PRE
A Multicenter Observational Study for the Establishment of Novel Severity Criteria Including Endoscopic Evaluation for Intestinal Behçet's Disease

一项多中心观察性研究,旨在建立包含内镜评估的新型肠道白塞病严重程度标准

2025-09-270
OAAI
Survival Benefit of Adjuvant S-1 Chemotherapy in Patients Aged ≥ 80 Years with Gastric Cancer after Curative Resection: A Multicenter Cohort Study

≥ 80岁胃癌患者根治术后辅助S-1化疗的生存获益:一项多中心队列研究

2025-09-240
PRE
Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)

优化卡托格斯特甲基在溃疡性结肠炎中的使用:患者特征分析、预测性生物标志物及疗效评估时机(ASPECT研究)

2025-09-220
OAAI
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure

Upadacitinib在克罗恩病中实现了临床和内镜结果,无论先前的生物暴露如何

2024-10-016
OAAI